Summary:
This clinical research study will compare the number of psychiatric hospital admissions in patients with schizophrenia, before and after switching from their regular schizophrenia medication to an investigational drug-device combination . The drug device combination is approved for use in adults with schizophrenia. However, in this clinical research study, the drug-device combination is investigational.
You may be able to take part in this clinical research study if you:
- Own an activated smartphone (mobile phone, cell phone)
- Have been taking antipsychotic medication for 6 months or longer
- Have been admitted to a psychiatric hospital at least once within the past 4 years
Qualified Participants May Receive:
If you take part, you will be in this clinical research study for up to 8.5 months. All study-related care and investigation drug-device combination will be provided to you at no cost.